Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001732510 | SCV001982671 | uncertain significance | not provided | 2022-04-28 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV001732510 | SCV002201198 | benign | not provided | 2023-12-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004980630 | SCV005557907 | uncertain significance | Inborn genetic diseases | 2024-07-10 | criteria provided, single submitter | clinical testing | The c.496C>T (p.R166W) alteration is located in exon 4 (coding exon 4) of the COL11A1 gene. This alteration results from a C to T substitution at nucleotide position 496, causing the arginine (R) at amino acid position 166 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |